ADR News Bulletin 2013 April (Volume 15 Number 1)

Bulletin Highlights:

  • Azithromycin and potential risk of QT prolongation
  • Intramuscular medroxyprogesterone and injection site necrosis and atrophy
  • AE case in focus: Test yourself
  • New enhancements to the medical device regulatory framework
  • Analysis of adverse event reports for Year 2012
  • Bupropion and possible increased risk of congenital cardiovascular malformations
  • Reminder on the safer use of NSAIDs
  • Levothyroxine and potential risk of fractures
  • Rivaroxaban (Xarelto®) and reports of lack of efficacy in orthopaedic surgery indication

Click on the link below to download the issue in pdf:


Healthcare professional, Industry member, Therapeutic Products

Adverse Drug Reaction News Bulletins

13 Nov 2019
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.